Mesoblast | MSB - Cost Of Sales


Mesoblast reported $9.06M in Cost of Sales for its fiscal semester ending in June of 2026.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Clinuvel Pharmaceuticals AUD 2.64M 1.06M Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Starpharma Holdings AUD 417K 459K Dec/2025
Telix Pharmaceuticals AUD 245.71M 24.35M Jun/2026